KazaniAMastorakiADastamaniC, et al. Myofibroblastoma of the breast: Diagnostic challenges of a rare benign tumor. Indian J Surg2013; 77: 501–504.
2.
SchatzlGTemmlCHaidingerG, et al. Cross-sectional study of nocturia in both sexes: Analysis of a voluntary health screening project. Urology2000; 56: 71–75.
3.
CornuJ-NAbramsPChappleCR, et al. A contemporary assessment of nocturia: Definition, epidemiology, pathophysiology, and management–a systematic review and meta-analysis. Eur Urol2012; 62: 877–890.
4.
TikkinenKAOTammelaTLJHuhtalaH, et al. Is nocturia equally common among men and women? A population based study in Finland. J Urol2006; 175: 596–600.
5.
AgarwalAEryuzluLNCartwrightR, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol2014; 65: 1211–1217.
6.
MadhuCCoyneKHashimH, et al. Nocturia: Risk factors and associated comorbidities; Findings from the EpiLUTS study. Int J Clin Pract2015; 69: 1508–1516.
7.
YoshimuraKTeradaNMatsuiY, et al. Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol2004; 11: 282–287.
8.
KurtzmanJTBergmanAMWeissJP.Nocturia in women. Vol. 26, Curr Opin Urol2016; 26: 315–320.
9.
KupelianVWeiJTO’LearyMP, et al. Nocturia and quality of life: Results from the Boston area community health survey. Eur Urol2012; 61: 78–84.
10.
WareJJKosinskiMMKellerSSD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care1996; 34: 220–233.
11.
WelliverCSulaverRWhittingtonA, et al. Analyzing why men seek treatment for lower urinary tract symptoms and factors associated with nonimprovement. Urology2015; 86: 862–867.
12.
AbramsPCardozoLFallM, et al. The standardization of terminology of lower urinary tract function: Report from the Standardisation Committee of the International Continence Society. Urology2003; 61: 37–49.
13.
AbramsPKlevmarkB.Frequency volume charts: An indispensable part of lower urinary tract assessment. Scand J Urol Nephrol Suppl1996; 179: 47–53.
14.
BoschJLHREveraertKWeissJP, et al. Would a new definition and classification of nocturia and nocturnal polyuria improve our management of patients? ICI-RS 2014. Neurourol Urodyn2016; 35: 283–287.
15.
Van KerrebroeckPAbramsPChaikinD, et al. The standardization of terminology in nocturia: Report from the standardization subcommittee of the International Continence Society. BJU Int2002; 61: 37–49.
16.
WeissJPWeinbergACBlaivasJG.New aspects of the classification of nocturia. Curr Urol Rep2008; 9: 362–367.
17.
AbramsPCardozoLFallM, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology2003; 61: 37–49.
18.
AbdelmotelebHKamelMIHashimH.The association between the ICIQ-LUTS and the ICIQ-bladder diary in assessing LUTS. Neurourol Urodyn2017; 36: 1601–1606.
19.
AbramsPAveryKGardenerN, et al. The international consultation on incontinence modular questionnaire: www.iciq.net. J Urol2006; 175: 1063–1066.
20.
UdoYNakaoMHonjoH, et al. Analysis of nocturia with 24-h urine volume, nocturnal urine volume, nocturnal bladder capacity and length of sleep duration: Concept for effective treatment modality. BJU Int2011; 107: 791–798.
21.
WeinALoseGRFondaD.Nocturia in men, women and the elderly: A practical approach. BJU Int2002; 90: 28–31.
22.
EpsteinMBlaivasJWeinAJ, et al. Nocturia treatment outcomes: Analysis of contributory frequency volume chart parameters. Neurourol Urodyn2017; 37: 186–191.
23.
BlankerMHBernsenRMDBoschJLHR, et al. Relation between nocturnal voiding frequency and nocturnal urine production in older men: A population-based study. Urology2002; 60: 612–616.
24.
GriffithsDJMccrackenPNHarrisonGM, et al. Relationship of fluid intake to voluntary micturition and urinary incontinence in geriatric patients. Neurourol Urodyn1993; 12: 1–7.
25.
GourovaLWVan De BeekCSpigtMG, et al. Predictive factors for nocturia in elderly men: A cross-sectional study in 21 general practices. BJU Int2006; 97: 528–532.
26.
WymanJF.Management of urinary incontinence in adult ambulatory care populations. Annu Rev Nurs Res2000; 18: 171–194.
27.
SugayaKNishijimaSOwanT, et al. Effects of walking exercise on nocturia in the elderly. Biomed Res2007; 28: 101–105.
28.
PaickJ-SKuJHShinJW, et al. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: A prospective study of response prediction. BJU Int2006; 97: 1017–1023.
29.
JohnsonTMIIJonesKWillifordWO, et al. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol2003; 170: 145–148.
30.
JohnsonTMBurrowsPKKusekJW, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol2007; 178: 2045–2051.
31.
BrubakerLFitzGeraldMP.Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct2007; 18: 737–741.
32.
KelleherCJReesePRPleilAM, et al. Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care2002; 8: S608–S6015.
33.
HommaYKawabeK.Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: A randomized, placebo-controlled trial. World J Urol2004; 22: 251–256.
34.
RudyDClineKHarrisR, et al. Multicenter phase III trial studying trospium chloride in patients with overactive bladder. Urology2006; 67: 275–280.
35.
OtsukaAShinboHMatsumotoR, et al. Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol2008; 377: 473–481.
36.
IgawaYAizawaNHommaY.Beta3-adrenoceptor agonists: Possible role in the treatment of overactive bladder. Korean J Urol2010; 51: 811–888.
37.
ChappleCRAmarencoGLõpez AramburuMA, et al. A proof-of-concept study: Mirabegron, a new therapy for overactive bladder. Neurourol Urodyn2013; 32: 1116–1122.
38.
YoshidaMGotohMKageyamaS, et al. 538 Mirabegron improves nocturia and nocturia associated QoL and sleep quality. Eur Urol Suppl2016; 15: e538–e538a.
39.
OuslanderJGNasrSZMillerM, et al. Arginine vasopressin levels in nursing home residents with nighttime urinary incontinence. J Am Geriatr Soc1998; 46: 1274–1279.
40.
OuslanderJSchnelleJSimmonsS, et al. The dark side of incontinence: Nighttime incontinence in nursing home residents. J Am Geriatr Soc1993; 41: 371–376.
41.
MatthiesenTBRittigSMortensenJT, et al. Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart. BJU Int1999; 83: 1017–1022.
42.
AsplundRAbergH.Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med1991; 229: 131–134.
43.
LoseGMattiassonAWalterS, et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol2004; 172: 1021–1025.
44.
WangC-JLinY-NHuangS-W, et al. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: A double-blind, placebo controlled, randomized study. J Urol2011; 185: 219–223.
45.
WadaNNumataAHouK, et al. Nocturia and sleep quality after transurethral resection of the prostate. Int J Urol2014; 21: 81–85.
46.
BuysseDJReynoldsCFMonkTH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res1989; 28:193–213.
47.
CoyneKSZhouZThompsonC, et al. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int2003; 92: 731–735.
48.
LeeSKKangHWKimWT, et al. Impact of transobturator tape treatment on overactive bladder symptoms, particularly nocturia, in patients with mixed urinary incontinence. Korean J Urol2014; 55: 520–526.
49.
HommaYYoshidaMSekiN, et al. Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score. Urology2006; 68: 318–323.
